Abstract
Novel disubstituted adamantyl derivatives were synthesized and evaluated in a P-glycoprotein dependent multidrug resistance cancer cell line. The hit to lead optimization provided potent MDR reversal agents. Some potent adamantyl derivatives were more than 10-fold more potent than verapamil without considerable intrinsic cytotoxicity. The 3-trifluorophenyl derivative 14f did not affect the metabolism of CYP450 3A4, whereas most of MDR revertants had a weak inhibitory effect.
| Original language | English |
|---|---|
| Pages (from-to) | 5376-5379 |
| Number of pages | 4 |
| Journal | Bioorganic and Medicinal Chemistry Letters |
| Volume | 19 |
| Issue number | 18 |
| DOIs | |
| State | Published - 15 Sep 2009 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- ABC transporter
- Adamantane
- CYP3A4
- MES-SA/DX5
- Multidrug resistance
- P-glycoprotein
Fingerprint
Dive into the research topics of 'A novel class of highly potent multidrug resistance reversal agents: Disubstituted adamantyl derivatives'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver